A Valdivieso

Summary

Country: Spain

Publications

  1. doi request reprint Management of hepatocellular carcinoma recurrence after liver transplantation
    A Valdivieso
    Hepatobiliary and Liver Transplantation Unit, Cruces University Hospital, Bilbao, Spain
    Transplant Proc 42:660-2. 2010
  2. doi request reprint Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center
    M Testillano
    Gastroenterology and Liver Unit, Hospital de Cruces, Bilbao, Vizcaya, Spain
    Transplant Proc 41:1041-3. 2009
  3. doi request reprint Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience
    M Montejo
    Unidad de Enfermedades Infecciosas y Servicios de Cirugía Hepáto biliar y Trasplante Hepático, Digestivo y Microbiología, Hospital Universitario de Cruces, Bilbao, Spain
    Transplant Proc 41:2189-91. 2009
  4. doi request reprint Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube
    M Gastaca
    Hepato biliary Surgery and Liver Transplantation Unit, Hospital Universitario de Cruces, Bilbao, Spain
    Transplant Proc 44:1554-6. 2012
  5. ncbi request reprint Donors older than 70 years in liver transplantation
    M Gastaca
    Liver Transplantation Unit, Hospital de Cruces, Bilbao, Spain
    Transplant Proc 37:3851-4. 2005

Detail Information

Publications5

  1. doi request reprint Management of hepatocellular carcinoma recurrence after liver transplantation
    A Valdivieso
    Hepatobiliary and Liver Transplantation Unit, Cruces University Hospital, Bilbao, Spain
    Transplant Proc 42:660-2. 2010
    ..There is a rationale for the use of sorafenib and mammalian target of rapamycin based immunosuppression, which warrants randomized studies...
  2. doi request reprint Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center
    M Testillano
    Gastroenterology and Liver Unit, Hospital de Cruces, Bilbao, Vizcaya, Spain
    Transplant Proc 41:1041-3. 2009
    ..Posttransplant hepatitis C virus (HCV) recurrence has been shown to negatively impact graft and patient survivals. It has been suggested that HCV recurrence among HIV- and HCV-coinfected transplant recipients is even more aggressive...
  3. doi request reprint Prophylactic therapy with valgancyclovir in high-risk (cytomegalovirus D+/R-) liver transplant recipients: a single-center experience
    M Montejo
    Unidad de Enfermedades Infecciosas y Servicios de Cirugía Hepáto biliar y Trasplante Hepático, Digestivo y Microbiología, Hospital Universitario de Cruces, Bilbao, Spain
    Transplant Proc 41:2189-91. 2009
    ..Treatment with intravenous gancyclovir followed by oral valgancyclovir was successful in both patients. No opportunistic infections were observed and only 1 patient developed leukopenia as an adverse event related to valgancyclovir...
  4. doi request reprint Biliary complications in orthotopic liver transplantation using choledochocholedochostomy with a T-tube
    M Gastaca
    Hepato biliary Surgery and Liver Transplantation Unit, Hospital Universitario de Cruces, Bilbao, Spain
    Transplant Proc 44:1554-6. 2012
    ..The complication rate after elective T-tube removal and the repeat surgery rate were extremely low. These results might challenge the current trend to avoid T-tube stenting in OLT...
  5. ncbi request reprint Donors older than 70 years in liver transplantation
    M Gastaca
    Liver Transplantation Unit, Hospital de Cruces, Bilbao, Spain
    Transplant Proc 37:3851-4. 2005
    ..Expansion of donor criteria has become necessary with the increasing number of liver transplantation candidates, as aged donors who have been considered to yield marginal organs...